Emerging drugs for schizophrenia.

Emerging drugs for schizophrenia.

Item
http://www.wikidata.org/entity/Q37874626
Cotinine: Beyond that Expected, More than a Biomarker of Tobacco Consumption.Neuropsychopharmacology of auditory hallucinations: insights from pharmacological functional MRI and perspectives for future research.Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents.The effects of bupropion on negative symptoms in schizophreniaPredictions of in vivo prolactin levels from in vitro K(i) values of D(2) receptor antagonists using an agonist-antagonist interaction model.A randomized placebo-controlled trial of an omega-3 fatty acid and vitamins E+C in schizophrenia.Is rational antipsychotic polytherapy feasible? A selective review.Drug treatment developments in schizophrenia and bipolar mania: latest evidence and clinical usefulness.Long-term effects of cariprazine exposure on dopamine receptor subtypes.
P2860

Emerging drugs for schizophrenia.

Item
http://www.wikidata.org/entity/Q37874626
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 May 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Emerging drugs for schizophrenia.
@en
Emerging drugs for schizophrenia.
@nl
type
label
Emerging drugs for schizophrenia.
@en
Emerging drugs for schizophrenia.
@nl
prefLabel
Emerging drugs for schizophrenia.
@en
Emerging drugs for schizophrenia.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
Emerging drugs for schizophrenia.
@en
P2093
P2860
P304
P31
P356
10.1517/14728214.2011.556112
P407
P433
P478
P577
P698
P921